| |
|
|
|
| |
 |
|
Nobel
Laureate Dr. Ferid Murad, M.D., Ph.D
Professor & Chairman
UTHSC at Houston, Medical School
Plenary Session I: Nitric Oxide To Viagra
and Numerous Biotech Companies and Products in Clinical Development
and Disease Markets. |
| |
| |
 |
|
Nobel
Laureate Dr. Eric Chivian, M.D.
Director, Center for Health and the Global
Environment
Harvard Medical School
Plenary Session II: Understanding
The Dependence Of Human Health On Nature |
| |
|
|
|
| |
 |
|
Gyan Parida, Ph.D.
President/CEO
SAEC, SAEC Ventures |
| |
|
|
|
| |
 |
|
Chris Kaster
Partner
MedVenture Associates |
| |
|
|
|
| |
 |
|
Investment Partner
Mitsui & Co. Venture Partners |
| |
|
|
|
| |
 |
|
Managing Partner
Cross Atlantic Partners |
| |
|
|
|
| |
 |
|
Managing Director, Life Sciences
Hercules Technology Growth Capital |
| |
|
|
|
| |
 |
|
,
M.D.
Managing Director
Cogene Ventures |
| |
|
|
|
| |
 |
|
General Partner
Spray Venture Partners |
| |
|
|
|
| |
 |
|
oshua
S. Phillips
Managing Director
Catalyst Health and Technology Partners |
| |
|
|
|
| |
 |
|
an
L. Garfinkle
Managing Partner, Founder
Arboretum Ventures |
| |
|
|
|
| |
 |
|
Vice President
Frazier Healthcare Ventures |
| |
|
|
|
| |
 |
|
Lewis M. Brown, Ph.D.
Asst Professor
School Of Medicine, University of Colorado |
| |
|
|
|
| |
 |
|
General Partner
Seaflower Ventures |
| |
|
|
|
| |
 |
|
A. Dana Callow, Jr.
Managing General Partner
Boston Millennia Partners |
| |
|
|
|
| |
 |
|
Jesse I. Treu, Ph.D
General Partner
Domain Associates |
| |
|
|
|
| |
 |
|
General Partner
EDF Ventures |
| |
|
|
|
| |
 |
|
Steven St. Peter, M.D.
General Partner
MPM Capital |
| |
|
|
|
| |
 |
|
Muz Mansuri, Ph.D.
General Partner
Flagship Ventures |
| |
|
|
|
| |
 |
|
Elaine V. Jones, Ph.D.
General Partner
Euclid SR Partners |
| |
|
|
|
| |
 |
|
Arthur H. Tinkelenberg, Ph.D.
Principal
Ascent Biomedical Ventures |
| |
|
|
|
| |
 |
|
Arthur
Klausner
Partner
A.M. Pappas & Associates |
| |
|
|
|
| |
 |
|
Lorenzo Pellegrini, Ph.D.
Principal
Care Capital |
| |
|
|
|
| |
 |
|
David Milne
General Partner
SV Life Sciences Advisers |
| |
|
|
|
| |
 |
|
John H. Friedman
Managing Partner
Easton Capital |
| |
|
|
|
| |
 |
|
Geoffrey W. Smith
Managing Partner
Ascent Biomedical Ventures |
| |
|
|
|
| |
 |
|
Mike Kaswan
Managing Director
KBL Healthcare Ventures |
| |
|
|
|
| |
 |
|
Philippe Chambon, Ph.D., M.D.
Managing Director
New Leaf Venture Partners |
| |
|
|
|
